|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | (2006.01) |
| A61K 31/517 | (2006.01) | ||
| A61P 13/02 | (2006.01) |
| (11) | Number of the document | 3490580 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17746197.7 |
| Date of filing the European patent application | 2017-07-14 | |
| (97) | Date of publication of the European application | 2019-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/054277 |
| Date | 2017-07-14 |
| (87) | Number | WO 2018/020355 |
| Date | 2018-02-01 |
| (30) | Number | Date | Country code |
| 201615222365 | 2016-07-28 | US |
| (72) |
AVERBACK, Paul , BS
|
| (73) |
Nymox Corporation ,
777 Terrace Avenue, Hasbrouck Heights, New Jersey 07604,
US
|
| (54) | NTP PEPTIDES FOR USE IN PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION |
| NTP PEPTIDES FOR USE IN PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION |